NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Vertex Pharmaceuticals


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Accuray Announces Additions to Board of Directors
2009 SEP 28 ... Winger also serves on the boards of directors of Cell Genesys, Inc., Cephalon, Inc. and Vertex Pharmaceuticals. "We are pleased to have two of the industry's most skilled veterans join ...
Subject: Accuray Incorporated
Price: $3.00
*
Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration
2009 NOV 23 ... and technical problems, announced that it has entered into a collaboration with Vertex Pharmaceuticals Incorporated, a global biotechnology company headquartered in Cambridge, MA. ...
Subject: Pharmaceuticals
Price: $3.00
*
Critical Alerts for Wells Fargo, Alcoa, Hess, Sears, and Vertex Pharmaceuticals Released by Seven Summits Research
2009 AUG 17 ... (NYSE:AA), Hess Corporation (NYSE:HES), Sears Holdings Corporation (NASDAQ:SHLD), and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In today's unsure markets these brief ...
Subject: Seven Summits Investment Research
Price: $3.00
*
Interim Results from Study 107 Highlight the Potential Role of Telaprevir-Based Regimens in HCV Patients Who Failed Prior Treatment
2009 NOV 9 ... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that treatment with telaprevir-based regimens in ...
Subject: Vertex Pharmaceuticals Incorporated
Price: $3.00
*
Leerink Swann Advances Investment Banking Franchise with Key New Hires
2009 AUG 3 ... in industry. Recent notable transactions include advising Virochem Pharma on its sale to Vertex Pharmaceuticals and advising Axcan Pharma on its sale to Texas Pacific Group. Tony earned a B.A. from ...
Subject: Leerink Swann
Price: $3.00
*
More than 80% of Hepatitis C Patients Treated in Study C208 Achieved an SVR with Telaprevir-Based Regimens
2009 NOV 16 ... regimen according to results of an intent-to-treat (ITT) analysis announced by Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX). The data from Study C208 will be presented in an oral ...
Subject: Anemia
Price: $3.00
*
Pyro Pharmaceuticals, Inc. Announces the Appointment of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board
2009 NOV 23 ... boards of major pharmaceutical and biotechnology companies including Merck, Glaxo, Vertex, Chiron, Abbott, Bristol Myers Squibb, Rhone-Poulenc Rorer, and Hoechst Marion Roussel. ... of Robert C. Moellering, Jr., M.D. as Chairman of the Scientific Advisory Board of Pyro Pharmaceuticals, Inc. As previously announced, the Company has executed a share exchange agreement with ...
Subject: Fero Industries, Inc.
Price: $3.00
*
Reports on midwifery findings from G. Eichenbaumpikser and co-researchers provide new insights
2009 AUG 27 ... vaginal examination on arrival was 5 cm dilatation, 50% effaced, and -2 station of the vertex, with intact membranes. Her contractions were occurring every 3 to 5 minutes. Shortly ... United States, New York, Life Sciences, Surgery, Amniotomy, Breastfeeding, Oxytocin, Pharmaceuticals, Drugs, Therapy, Treatment, Midwifery, Gynecology, Midwifery and Women's Health. ...
Subject: Midwifery
Price: $3.00
*
Research on midwifery described by S. Church and colleagues
2009 NOV 5 ... admission was I cm dilated, 50% effaced, medium consistency and posterior, -3 station, vertex presentation, equivalent to a Bishop score of 3, with membranes intact. The NST ... Screening, Obstetrics, Cervical Ripening, Women's Health, Gynecology, Dinoprostone, Pharmaceuticals, Drugs, Therapy, Treatment, Misoprostol, Cervidil, Cytotec, Midwifery, Midwifery and ...
Subject: Midwifery
Price: $3.00
*
Ric Andersen Named to ProtonMedia's Board of Directors
2009 AUG 11 ... of technology and professional services companies, and currently serves on the board of Vertex, Inc. "ProtonMedia is a clear leader in delivering the business value of ... China, Advertising, Asia, Chevron, Energy, Marketing, Oil & Gas, Technology, Pharmaceuticals. This article was prepared by Drug Law Weekly editors from staff and other ...
Subject: ProtonMedia
Price: $3.00
*
Riley Hospital First Site in Nation to Enroll Patients in Clinical Trial of Promising Cystic Fibrosis Drug
2009 NOV 1 ... the activity of defective CFTR proteins at the cell surface. VX-770 was discovered by Vertex Pharmaceuticals as part of a collaboration with the Cystic Fibrosis Foundation. "We are ...
Subject: The Riley Hospital for Children
Price: $3.00
*
Study data from C.A.L. Gaffaney and co-authors update knowledge of women's health
2009 NOV 9 ... gestation with well-dated pregnancies, singleton gestations, Bishop scores less than 6, vertex presentations, and intact membranes." "received either oral misoprostol ... Ripening, Clinical Trial Research, Drugs, Misoprostol, Obstetrics, Perinatology, Pharmaceuticals, Pregnancy, Prolonged Pregnancy, Therapy, Treatment, Women's Health. This ...
Subject: Women's Health
Price: $3.00
*
StudyManager Expands to China
2009 NOV 16 ... is led and managed by Feng Cheng, former Sr. Director of Information Systems for Vertex Pharmaceuticals, and a 20-year industry veteran. About StudyManager ...
Subject: Clinical Trial Research
Price: $3.00
*
Third Rock Ventures Expands Team with Biotech Veterans
2009 AUG 3 ... of DNA damage recognition and repair. Verdine was a founding scientific advisor to Vertex Pharmaceuticals, he served a key advisory role in the re-founding of Variagenics, Inc., and he ...
Subject: Third Rock Ventures L.L.C.
Price: $3.00
*
Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia
2009 AUG 10 ... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Mitsubishi Tanabe Pharma Corporation today amended their ...
Subject: Vertex Pharmaceuticals Incorporated
Price: $3.00
*
Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting
2009 OCT 12 ... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that sustained virologic response (SVR) data from ...
Subject: Vertex Pharmaceuticals Incorporated
Price: $3.00
*
Vertex Pharmaceuticals Announces Webcast of its Presentations at Two Investor Conferences
2009 SEP 28 ... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it will webcast its presentations at the UBS ...
Subject: Vertex Pharmaceuticals Incorporated
Price: $3.00
*
Vertex Pharmaceuticals Provides Corporate Update
2009 OCT 12 ... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it plans to initiate a Phase 2 ...
Subject: Vertex Pharmaceuticals Incorporated
Price: $3.00
*
Vertex Pharmaceuticals to Receive $155 Million in Cash Related to Future Telaprevir Milestone Payments
2009 OCT 12 ... Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it will receive $155 million in cash from two ...
Subject: Vertex Pharmaceuticals Incorporated
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login